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ABSTRACT 
Natural killer (NK) cells are lymphocytes that belong to the innate immune system. 
They are important for the early defense against viral infections and provide tumor 
immune surveillance against both solid tumors and leukemias as well as in settings 
of hematopoietic stem cell transplantation. They also play an important role in 
human pregnancy via spiral artery modulation, and deliver signals that shape 
adaptive immune responses. However, despite these insights, several unresolved 
issues remain with regards to mechanisms by which NK cells respond in these and 
other conditions. In this thesis, NK cell activation and differentiation in healthy 
uninfected individuals as well as in defined acute and chronic viral infections are 
characterized.  
Via a detailed analysis of NK cell repertoires in the healthy humans and in two 
specific settings of immune system development, we have provided evidence that 
human CD56dim NK cells undergo a previously undescribed differentiation process. 
This differentiation process can, at steady state, be defined by analysis of expression 
patterns of NKG2A, KIRs, and CD57 on CD56dim NK cells. Distinct differentiation 
stages identified are associated with phenotypic and functional changes. This 
knowledge formed a platform for studies of human NK cells in settings of defined 
viral infections. In acute human hantavirus infection, the NK cell response 
encompassed a rapid and vigorous proliferation of activated NK cells followed by 
long-term persistence of a differentiated NKG2C+CD57+ CD56dim NK cell subset. 
Surprisingly, this proliferation and persistence occurred only in patients on a CMV 
seropositive background and was mediated by IL-15 and HLA-E, providing 
necessary proliferative and anti-apoptotic signals to the expanding cells. When 
monitoring the NK cell response to immune modulatory IFN-α treatment in the 
context of acute and chronic hepatitis C virus (HCV) infection, we observed that 
CD56bright NK cells acquired the capacity to express the apoptosis-inducing 
molecule TRAIL. These differentiated CD56bright ‘killer’ cells efficiently inhibited 
HCV replication in Huh7.5 cells via TRAIL. NK cells could also utilize the 
activation receptor DNAM-1 to recognize Huh7.5 cells and suppress HCV 
replication. Chronic HCV-infection was found to cause disturbances in innate 
cellular immunity. One example of this was the differentiation of NK cells towards a 
functionally skewed CD56neg NK cell subset. Furthermore, effector CD8 T cells 
acquired NK cell-like properties, such as expression of CD16 and the capacity to 
respond independent of the TCR during chronic HCV infection. 
Altogether, the described model of human CD56dim NK cell differentiation may 
serve as a framework for studies of NK cell responses in many disease conditions, 
here illustrated in studies of viral infections in humans. 
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